Why the study?
The study was conducted to evaluate the efficacy, safety, and effectiveness of thrombolytic therapy compared to standard treatment in patients with acute deep vein thrombosis.
Does thrombolytic therapy improve clinical outcomes and reduce post-thrombotic syndrome compared to standard treatment in patients with acute deep venous thrombosis?
Population
1309 participants across 9 RCTs in 6 countries
Comparison
Thrombolytic therapy vs standard treatment
Design
Systematic review of randomized controlled trials
Authors
Loading...
May warrant selective thrombolysis in iliofemoral DVT to reduce PTS; extends RCT evidence on administration routes.
Does thrombolytic therapy improve clinical outcomes and reduce post-thrombotic syndrome compared to standard treatment in patients with acute deep venous thrombosis?
Thrombolytic therapy for acute DVT improves venous patency and significantly reduces long-term post-thrombotic syndrome compared to standard anticoagulation, though it carries a higher risk of major bleeding.
Birhan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: